Journal: Journal of Neuroinflammation
Article Title: Sleep deprivation induces anxiety-like behaviors through IL-6 driven astrocyte-GABAergic neuron crosstalk in the PAG-ACC circuit
doi: 10.1186/s12974-026-03879-z
Figure Lengend Snippet: Sleep deprivation induced anxiety-like behaviors and increased pro-inflammatory cytokine IL-6 in blood and midbrain. A Schematic diagram of the behavioral experimental paradigm. B Representative heatmaps of mouse movement in the open field test (OFT) in the control group and the sleep deprivation (SD) group. C The number of entries into the center zone and the time spent in the center zone during the OFT ( n = 10). D Representative heatmaps of mouse movement in the elevated plus maze (EPM) test in the control group and the SD group. E The number of entries into the open arms and the time spent in the open arms during the EPM test ( n = 10). F Flowchart illustrating the timeline for tissue collection. G-I Serum concentrations of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in the control group ( n = 6) and the SD group ( n = 10). J-M mRNA expression levels of IL-1β , IL-6 , and TNF-α in the cerebral cortex, thalamus, midbrain and oblongata in both groups ( n = 4). N Representative immunofluorescence images showing co‑localization of Iba1 and IL‑6 in the midbrain after sleep deprivation (SD). Scale bar:50 μm. O Representative immunofluorescence images of Iba1 expression after treatment with PLX5622 or control diet. Scale bar: 50 μm. P Representative heatmaps of mouse movement in the OFT in the control group and the PLX5622‑treated group. Q The number of entries into the center zone and the time spent in the center zone during the OFT ( n = 10). R Representative heatmaps of mouse movement in the EPM test in the control group and the PLX5622‑treated group. S The number of entries into the open arms and the time spent in the open arms during the EPM test ( n = 10). Data were presented as mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: Following a 7-day recovery, the solution of IL-6 receptor antagonist (IL-6Ra) (HY- P10284 , MedChemExpress, USA), GABA receptor antagonist (GABARa) (HY-W008645, MedChemExpress, USA), NMDA receptor antagonist AP5 (HY-100714 A, MedChemExpress, USA), AMPA receptor antagonist CNQX (HY-15066, MedChemExpress, USA) or vehicle was administered using a micro-infusion pump connected to an internal injector (R462, RWD Life Science, China) that extended 0.5 mm beyond the tip of the guide cannula.
Techniques: Control, Expressing, Immunofluorescence